Oncoinvent ASA (ONCIN) — Financial Flexibility Index
Oncoinvent ASA (ONCIN) has a Financial Flexibility Index of -3.74x as of June 2025. Free cash flow of Nkr-73.90 Million (operating CF Nkr-73.90 Million minus capex Nkr0.00) represents -4% of total liabilities (Nkr19.75 Million). Check asset allocation strategy of Oncoinvent ASA to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Oncoinvent ASA Financial Flexibility Index (2021–2025)
Historical Financial Flexibility Index trend for Oncoinvent ASA across 5 annual periods. See Oncoinvent ASA working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Oncoinvent ASA (2021–2025)
Year-by-year free cash flow to debt coverage for Oncoinvent ASA. For the full company profile including market capitalisation, see Oncoinvent ASA market capitalisation.
| Year | Flexibility Index | Free Cash Flow (NOK) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -2.24x | Nkr-131.07 Million | Nkr-131.19 Million | Nkr58.63 Million | ▲ +7.5% |
| 2024 | -2.42x | Nkr-151.44 Million | Nkr-153.24 Million | Nkr62.68 Million | ▼ -1.7% |
| 2023 | -2.37x | Nkr-111.29 Million | Nkr-138.11 Million | Nkr46.86 Million | ▲ +34.7% |
| 2022 | -3.63x | Nkr-284.25 Million | Nkr-288.23 Million | Nkr78.21 Million | ▲ +21.2% |
| 2021 | -4.61x | Nkr-303.34 Million | Nkr-303.34 Million | Nkr65.81 Million | — |